Advancing evidence-generating medicine
Osmind’s research is helping to set new standards for mental health interventions and improve patient outcomes. See how we work with research partners to generate real-world evidence to accelerate advances in mental health care.
Selected research projects
Psilocybin services and mental health outcomes within Oregon’s state-regulated model
Gow, A., Shih, E., Reid, R., Qian, J. J., Mellor, C., McInnes, L. A., Carhart-Harris, R., & Davis, J. N. (2026). Psilocybin services and mental health outcomes within Oregon's state-regulated model. *medRxiv* 2026.
Osmind Supports Successful FDA Type C Meeting in Support of New Drug Application
Osmind partners with LivaNova to Support Education and Awareness for Clinicians Caring for People Living with Difficult-to-treat Depression
Ketamine Infusion Therapy for PTSD: Real World Outcomes in over 8,000 patients
McInnes, L. A., Berman, R. M., & Shih, E. (2026). Ketamine infusion therapy for PTSD: Real-world outcomes in over 8,000 patients. Symposium presentation at the ASKP Annual Meeting, January 2026.
Osmind provides regulatory-grade RWE in support of New Drug Application
Differential Associations of Body Mass Index with Depression, Anxiety, and PTSD Symptom Trajectories in Patients Receiving Ketamine Infusion Therapy in the Real World
Sauvé, W., McIntyre, R., Qian, J., McInnes, L.A., Berman, R.M., Shih, E. (2025). Differential Associations of Body Mass Index with Depression, Anxiety, and PTSD Symptom Trajectories in Patients Receiving Ketamine Infusion Therapy in the Real World. Poster presented at ACNP Annual Meeting, Paradise Island, Bahamas.
Let's transform mental health together
Click here to learn more about our research or to discuss collaboration opportunities.
